News Europe Maltese Medical Cannabis To Boost Exports

Maltese Medical Cannabis To Boost Exports



THE Maltese approach to cannabis is set to see its total value of exports increase by 30%.

Malta decriminalised cannabis in 2013, and legalised medical cannabis in March, 2018 and has since made significant strides in becoming a leading player in the emerging European market.

In an interview with Health Europa in 2019 Marion Zammit of Malta Enterprise confirmed over 20 projects had been approved.

She said these included Canadian, Australian and US companies. In June, last year Aphria’s Malta subsidiary, ASG Pharma, received an import license from The Malta Medicines Authority.

Malta Enterprise has granted Canadian firm Aurora approval for a seed-to-pharma operation in partnership with local firm Cherubino.

Australian firm MGC Pharmaceuticals signed a deal with the Maltese government which will see it create an € 11m medical cannabis manufacturing plant.

Whilst Toronto firms MPXI and Supreme and US firm Columbia Care, are also amongst the 20 approved projects. 

Ms Zammit went on to say that once all approved projects are in operational it ‘will supplement exports by an additional 30%’, adding: “We are creating a new sub-niche in the manufacturing sector and this in turn will make our economy more robust.”

Malta, a small Mediterranean island with a population of less than half a million, has a strong advanced manufacturing and pharmaceutical base.

It promotes itself as being in an ‘ideal geographic location capable of  bridging continents’, with English being the language of choice for business. 

MGC Pharmaceuticals founder and director Nativ Segev said its move allows it to be a ‘part of Malta’s drive to become a beacon in Europe for the growth and development of this industry’. 

Economy Minister Chris Cardona said that as the first country in the EU to provide a regulatory framework for medical cannabis ‘it has been able to attract the best investment to our country, with the sector already contributing to economic growth’.

Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.


Please enter your comment!
Please enter your name here

Latest news

European Moves To Brand CBD A ‘Narcotic’ Are A Growing Threat To Industry

MOVES are underway in Brussels to the restrict the sale of CBD across Europe with questions being...

UK CBD Pioneers To More Than Double Sales To Over £6m Following Canadian Takeover

CBD brand Love Hemp has been turbo-charged following its purchase by North American investors as it looks...

Legal UK Cannabis Industry Mapped Out For First Time – And Poised For Rapid Change

SOME say it's journalists who sketch history’s initial draft but this attempt to map-out the UK’s cannabis...

CBD Firms To Get Key Opportunity To Quiz FSA On Novel Food Compliance – For Free

THE European CBD industry is being given an opportunity to quiz UK regulators over the thorny issue...


UK Medicinal Cannabis Impasse – ‘Companies Won’t Invest In Clinical Trials; Medics Only Want Clinical Trials’

A WORLD-LEADING cannabis professor says the UK is caught in a depressing Catch-22 with companies unwilling to...

Europe’s Capital Markets Poised To Open-Up To The Cannabis Industry

THE European public markets are still a capital cocoon for cannabis with regulatory issues and the recent...

Must read


You might also likeRELATED
Recommended to you